
Revised outcome of Board Meeting held on 24/03/2026 incorporating additional details in compliance with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.
Filed with BSE ·

Revised outcome of Board Meeting held on 24/03/2026 incorporating additional details in compliance with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.
6ix hasn’t read this filing yet.
Follow Aptus Pharma into a list and get an email when it puts out news.
Follow Aptus Pharma